UKVIA Hosts April E-cigarette Industry Conference in London

Mar.29.2023
UKVIA Hosts April E-cigarette Industry Conference in London
UKVIA held a meeting in London discussing e-cigarette regulation, underage use, and environmental impact.

On March 28th, the UK Vaping Industry Association (UKVIA) held its April conference at the Churchill Hall in London. Attendees included John Dunne, Director of UKVIA, Adam Afriyie, Member of Parliament, representatives from UKVIA member organizations, and Jason, the International Business Manager for 2FIRSTS.


During the meeting, Adam Afriyie acknowledged the harm reduction benefits of electronic cigarettes and encouraged those in the e-cigarette industry to take pride in their work, as it has made significant contributions to healthcare in the UK.


Adam Afriyie has stated that the UK electronic cigarette industry is facing two major problems. The first is the issue of non-compliant products in the market, and the second is the problem of underage e-cigarette use.


Adam Afriyie said that the UK Parliament is discussing a bill aimed at banning all disposable e-cigarette products from the UK market.


If the e-cigarette industry doesn't control these two problems, then I may support a bill to ban disposable e-cigarettes," said Adam Afriyie.


Adam Afriyie delivers speech at Churchill Hall | Image source: 2FIRSTS


In response, John suggested that UKVIA propose immediate fines of up to £10,000 for retailers selling e-cigarette products to minors. He also suggested that individual fines should be issued to responsible individuals in retail shops and to directors. It is currently known that the currently imposed fine for such violations in the UK is £2,500.


John has stated that UKVIA has released a green paper in response to the current debate surrounding the environmental impact of electronic cigarettes in the UK. Various individuals involved in the electronic cigarette industry, such as manufacturers, retailers, waste management professionals, consumer behavior experts, and government regulatory agencies, have been gathered to propose solutions to reduce environmental impact. The goal is to ensure that effective measures are taken to solve the issue at hand.


At the conference site | Image source: 2FIRSTS


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Canadian Conservative MP’s Promotion of Zyn Draws Opposition From Local Nicotine Pouch Brand
Canadian Conservative MP’s Promotion of Zyn Draws Opposition From Local Nicotine Pouch Brand
Conservative MP Jamil Jivani’s public support for nicotine pouch brand Zyn has drawn attention on Canadian university campuses, but Imperial Tobacco, which makes the only similar Canadian product, Zonnic, said it does not support the promotion of an unauthorized competitor.
Mar.18 by 2FIRSTS.ai
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
From Tamarind’s AI Shift to Industry Restructuring, The ‘Amazon Moment’ for Nicotine Is Approaching
Tamarind Intelligence’s decision to appoint a technology-sector executive as chief executive officer signals more than a leadership reshuffle at a specialist data firm. It reflects a broader structural shift across the global nicotine industry, where companies, regulators and intelligence providers are embedding artificial intelligence into core operations.
Special Report
Feb.18
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Russian Lawmaker Says Bill on Full Vape Sales Ban Is Before State Duma
Russian Lawmaker Says Bill on Full Vape Sales Ban Is Before State Duma
Yaroslav Nilov, chair of the State Duma Committee on Labour, Social Policy and Veterans’ Affairs, said a bill proposing a full ban on vape sales is currently before the State Duma, though no final decision has yet been made. He said the initiative has been signed by representatives of almost all factions and noted that support for a full ban has also been voiced at the regional governor level. Nilov also said vape use in Russia is increasing while the age of consumers is declining.
Mar.12 by 2FIRSTS.ai
Special Report | Middle East Military Conflict Disrupts Global Air Corridors: Europe-Bound Vape Logistics Defy Seasonal Price Declines, Fuel Cost Risks Emerge
Special Report | Middle East Military Conflict Disrupts Global Air Corridors: Europe-Bound Vape Logistics Defy Seasonal Price Declines, Fuel Cost Risks Emerge
Escalating tensions involving Iran are disrupting air transit routes heavily used for China’s vape exports to Europe, preventing the usual post–Lunar New Year freight rate decline. While Europe-bound capacity reliant on Middle East hubs faces pressure, shipments to the United States remain largely unaffected for now. However, potential jet fuel price increases could broaden cost pressures globally.
Special Report
Mar.02
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24